Future Science Group
Johanna Todd currently serves as a Senior Commissioning Editor at Taylor & Francis Group since April 2024 and has been with Future Science Group since January 2017, initially as a Commissioning Editor for Drug Evaluations before advancing to the Senior Commissioning Editor role. Johanna Todd earned a BSc in Cognitive Neuroscience from the University of Westminster, with studies completed between 2012 and 2016.
Future Science Group
VISION IN SCIENTIFIC AND MEDICAL PUBLISHING Founded in 2001, Future Science Group is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. Future Science Group’s portfolio consists of two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, Future Science Group develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Pharmacogenomics and the award-winning Regenerative Medicine. The aim of Future Science Group is to serve the advancement of clinical practice and drug research by enhancing the efficiency of communication among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. Learn more about Future Science Group at www.future-science-group.com